CinCor Pharma, Inc.
Total Trades
18
Buys
16
Sells
2
Largest Trade
$1M+
Insiders
10
Institutional Funds
3
Inst. Value
$500K+
Activist Filings
16
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| HEALY JAMES | Director | SELL | $50K–$100K | 6K | $14.32 | Feb 28, 2023 |
| Freeman Mason | Chief Medical Offi… | SELL | <$1K | 6 | $15.21 | Feb 27, 2023 |
| 5AM Partners VI, LLC | 10% Owner | BUY | $1M+ | 600K | $30.00 | Aug 18, 2022 |
| Sofinnova Partners SAS | 10% Owner | BUY | $1M+ | 133K | $30.00 | Aug 17, 2022 |
| Sofinnova Venture Partners X, L.P. | 10% Owner | BUY | $1M+ | 500K | $30.00 | Aug 15, 2022 |
| HEALY JAMES | Director | BUY | $1M+ | 506K | $30.00 | Aug 15, 2022 |
| GENERAL ATLANTIC GENPAR (BERMUDA), L.P. | 10% Owner | BUY | $1M+ | 83K | $30.00 | Aug 15, 2022 |
| GENERAL ATLANTIC, L.P. | 10% Owner | BUY | $1M+ | 83K | $30.00 | Aug 15, 2022 |
| GENERAL ATLANTIC GENPAR (BERMUDA), L.P. | 10% Owner | BUY | $1M+ | 1.7M | $16.00 | Jan 14, 2022 |
| GENERAL ATLANTIC, L.P. | 10% Owner | BUY | $1M+ | 1.7M | $16.00 | Jan 14, 2022 |
| 5AM Partners VI, LLC | 10% Owner | BUY | $1M+ | 470K | $16.00 | Jan 13, 2022 |
| Sofinnova Venture Partners X, L.P. | 10% Owner | BUY | $1M+ | 325K | $16.00 | Jan 13, 2022 |
| Sofinnova Partners SAS | 10% Owner | BUY | $1M+ | 220K | $16.00 | Jan 13, 2022 |
| HEALY JAMES | Director | BUY | $1M+ | 325K | $16.00 | Jan 13, 2022 |
| Pearce Catherine | COO | BUY | $15K–$50K | 2K | $16.00 | Jan 13, 2022 |
| Freeman Mason | EVP Clinical Devel… | BUY | $15K–$50K | 3K | $16.00 | Jan 13, 2022 |
| de Garidel Marc | CEO | BUY | $100K–$500K | 13K | $16.00 | Jan 13, 2022 |
| Coelho Mary Theresa | EVP CFO & Chief BD… | BUY | $1K–$15K | 100 | $16.00 | Jan 13, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2022 · 3 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Jefferies Financial Group Inc. | 30K | $100K–$500K | SH (Call) |
| NEW YORK STATE COMMON RETIREMENT FUND | 15K | $100K–$500K | SH |
| METROPOLITAN LIFE INSURANCE CO/NY | 2K | $15K–$50K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Sofinnova Capital IX FPCI (“SC IX”) 2.
SC 13D/A · Mar 3, 2023
14.0%
12 shares
Sofinnova Venture Partners X, L.P. (“SVP X”)
SC 13D/A · Mar 1, 2023
0.0%
0 shares
SC 13D/A · Feb 28, 2023
0.0%
0 shares
SC 13D/A · Feb 28, 2023
0.0%
0 shares
SC 13G · Feb 14, 2023
5.9%
2.6M shares
Sofinnova Capital IX FPCI (“SC IX”) 2.
SC 13D · Feb 13, 2023
9.6%
422.1M shares
SC 13D · Jan 18, 2023
9.0%
4.0M shares
SC 13D/A · Jan 11, 2023
9.6%
4.2M shares
venBio Global Strategic Fund III, L.P.
SC 13G/A · Sep 26, 2022
4.9%
1.9M shares
Sofinnova Venture Partners X, L.P. (“SVP X”)
SC 13D/A · Aug 19, 2022
14.3%
6.1M shares
SC 13G · Jan 21, 2022
5.9%
2.1M shares
SC 13G · Jan 21, 2022
10.5%
3.8M shares
Sofinnova Venture Partners X, L.P. (“SVP X”)
SC 13D · Jan 21, 2022
15.3%
5.6M shares
SC 13D · Jan 21, 2022
11.3%
4.1M shares
venBio Global Strategic Fund III, L.P.
SC 13G · Jan 11, 2022
5.6%
2.0M shares
SC 13G · Jan 11, 2022
7.8%
3.6M shares